Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioTime, Inc. (NY: BTX)
4.380 USD  +0.200 (+4.78%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about BioTime, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
May 23, 2013
The Israeli Office of the Chief Scientist Approved Cell Cure's Development Budget Totaling NIS 11.5 Million (Over $3 Million USD) with non equity based funding of close to 50% Read More
from PR Newswire
BioTime Announces Results of Vote at Special Meeting of Shareholders
May 23, 2013
from Business Wire News Releases
BioTime CEO Dr. Michael West to Present at USC Minisymposium: Musculoskeletal Development and Repair
May 20, 2013
from Business Wire News Releases
BioTime Appoints Franklin Berger to Board of Directors
May 14, 2013
from Business Wire News Releases
BioTime (BTX) Subsidiary Cell Cure Neurosciences Receives $1.5 Million Grant from Israeli Agency
May 14, 2013
category Stocks
from TransWorldNews Current Releases
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
May 13, 2013
from Business Wire News Releases
BioTime Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments
May 10, 2013
from Business Wire News Releases
PDL BioPharma Announces First Quarter 2013 Financial Results
May 09, 2013
from PR Newswire
BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research
May 07, 2013
from Business Wire News Releases
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
April 30, 2013
from PR Newswire
Could We Be in a Blossoming Market?
April 30, 2013
The 6 W’s: Who, what, where, when, why and what of it RegMed stocks were almost evenly split at mid-day, as financing announcements take center stage.  Along with slight increases in investor optimism... Read More
category Henry McCusker
from Bio-Wire.Com
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.10
April 30, 2013
from Business Wire News Releases
BioTime Announces CFO Succession Plan
April 29, 2013
from Business Wire News Releases
LifeMap Sciences Announces Partnership With Appistry
April 23, 2013
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE: BTX ), announced today a collaborative partnership and value-added reseller agreement with Appistry, Inc., which provides big-data computing... Read More
category Benzinga , BTX , News
from Latest Articles from Benzinga.com
LifeMap Sciences, a Subsidiary of BioTime, Announces Partnership with Appistry
April 23, 2013
from Business Wire News Releases
BioTime Announces License Deal with UCLA
April 19, 2013
BioTime, Inc. (NYSE: BTX ) today announced that it has entered into an exclusive license agreement with the University of California, Los Angeles (UCLA) for novel technology related to the treatment of... Read More
category Contracts , Benzinga , BTX , and 1 more.
from Latest Articles from Benzinga.com
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
April 19, 2013
from Business Wire News Releases
LifeMap Sciences Announces Publication of Research Report Describing the MalaCards Database of Human Diseases
April 18, 2013
from Business Wire News Releases
Companies that Can Mend the Biotech Market: Stephen Brozak
April 11, 2013
Companies that Can Mend the Biotech Market: Stephen Brozak Source: George S. Mack of The Life Sciences Report (4/11/13) http://www.thelifesciencesreport.com/pub/na/15141 Markets are not efficient?at... Read More
category BTX , ASTM , ALXA , and 9 more.
from Bio-Wire.Com
LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGene
April 10, 2013
LifeMap Sciences, Inc., a subsidiary of BioTime (NYSE: BTX ), announced today that it is now offering 100 selected ProSpec-Tany TechnoGene (ProSpec) manufactured recombinant proteins related to stem... Read More
category Contracts , Benzinga , BTX , and 1 more.
from Latest Articles from Benzinga.com
LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGene
April 10, 2013
from Business Wire News Releases
BioTime's LifeMap Sciences Launches LifeMap Discovery Version 1.1
March 25, 2013
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE: BTX ), announced today the release of LifeMap Discovery^TM version 1.1 (discovery.lifemapsc.com). LifeMap Discovery^TM is a key component in... Read More
category Benzinga , BTX , News
from Latest Articles from Benzinga.com
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap DiscoveryTM Version 1.1 with Enhanced Therapeutic Discovery and Commercial Utility
March 25, 2013
from Business Wire News Releases
BioTime, Inc. (BTX) Widens Q4 Loss to 12c/Share
March 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8194126 for the full story. Read More
from StreetInsider.com News Articles
BioTime Announces Fourth Quarter and Fiscal Year End 2012 Financial Results and Recent Corporate Accomplishments
March 18, 2013
from Business Wire News Releases
ExecRank Honors David Jin, M.D., Ph.D. of BioTime Inc. as a Top Chief Medical Officer for 2012
March 18, 2013
from Business Wire News Releases
BioTime to Present at 25th Annual ROTH Conference
March 13, 2013
from Business Wire News Releases
BioTime Appoints Stephen C. Farrell to Board of Directors
March 12, 2013
from Business Wire News Releases
BioTime and Romulus Agree to Accelerate Closing Date for Second Tranche of $5 Million Financing
March 07, 2013
from Business Wire News Releases
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success in 2012
March 06, 2013
RDInvesting Provides Stocks Research on BioTime and Merrimack Pharmaceuticals Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here